Human in vivo phosphate metabolite imaging with 31P NMR
- PMID: 3205148
- DOI: 10.1002/mrm.1910070309
Human in vivo phosphate metabolite imaging with 31P NMR
Abstract
Phosphorus (31P) spectroscopic images showing the distribution of high-energy phosphate metabolites in the human brain have been obtained at 1.5 T in scan times of 8.5 to 34 min at 27 and 64 cm3 spatial resolution using pulsed phase-encoding gradient magnetic fields and three-dimensional Fourier transform (3DFT) techniques. Data were acquired as free induction decays with a quadrature volume NMR detection coil of a truncated geometry designed to optimize the signal-to-noise ratio on the coil axis on the assumption that the sample noise represents the dominant noise source, and self-shielded magnetic field gradient coils to minimize eddy-current effects. The images permit comparison of metabolic data acquired simultaneously from different locations in the brain, as well as metabolite quantification by inclusion of a vial containing a standard of known 31P concentration in the image array. Values for the NMR visible adenosine triphosphate in three individuals were about 3 mM of tissue. The ratio of NMR detectable phosphocreatine to ATP in brain was 1.15 +/- 0.17 SD in these experiments. Potential sources of random and systematic error in these and other 31P measurements are identified.
Similar articles
-
Quantitation of in vivo phosphorus metabolites in human brain with magnetic resonance spectroscopic imaging (MRSI).Magn Reson Imaging. 1993;11(2):273-8. doi: 10.1016/0730-725x(93)90033-a. Magn Reson Imaging. 1993. PMID: 8455438
-
31P FLASH NMR imaging.Magn Reson Med. 1988 Jul;7(3):358-63. doi: 10.1002/mrm.1910070314. Magn Reson Med. 1988. PMID: 3205152
-
Depletion of high-energy phosphates in the central nervous system of patients with systemic lupus erythematosus, as determined by phosphorus-31 nuclear magnetic resonance spectroscopy.Arthritis Rheum. 1990 Jun;33(6):827-33. doi: 10.1002/art.1780330609. Arthritis Rheum. 1990. PMID: 2363738
-
[Clinical efficacy of three-dimensional chemical shift imaging (3D-CSI)--a study of 3D-CSI in the human heart and its clinical perspectives for the future].Nihon Rinsho. 1997 Jul;55(7):1839-43. Nihon Rinsho. 1997. PMID: 9233037 Review. Japanese.
-
Absolute quantification of phosphorus metabolite concentrations in human muscle in vivo by 31P MRS: a quantitative review.NMR Biomed. 2007 Oct;20(6):555-65. doi: 10.1002/nbm.1192. NMR Biomed. 2007. PMID: 17628042 Review.
Cited by
-
Complementarity of magnetic resonance spectroscopy, positron emission tomography and single photon emission tomography for the in vivo investigation of human cardiac metabolism and neurotransmission.Eur J Nucl Med. 1991;18(11):897-923. doi: 10.1007/BF02258457. Eur J Nucl Med. 1991. PMID: 1661237 Review.
-
Screening and Targeting Risk Factors for Prodromal Synucleinopathy: Taking Steps toward a Prescriptive Multi-modal Framework.Aging Dis. 2023 Aug 1;14(4):1243-1263. doi: 10.14336/AD.2022.1024. Aging Dis. 2023. PMID: 37307836 Free PMC article. Review.
-
Spectrally selective 3D TSE imaging of phosphocreatine in the human calf muscle at 3 T.Magn Reson Med. 2013 Mar 1;69(3):812-7. doi: 10.1002/mrm.24288. Epub 2012 Apr 12. Magn Reson Med. 2013. PMID: 22499078 Free PMC article.
-
Dynamic three-dimensional imaging of phosphocreatine recovery kinetics in the human lower leg muscles at 3T and 7T: a preliminary study.NMR Biomed. 2013 Mar;26(3):348-56. doi: 10.1002/nbm.2866. Epub 2012 Oct 13. NMR Biomed. 2013. PMID: 23065754 Free PMC article.
-
3D-mapping of phosphocreatine concentration in the human calf muscle at 7 T: comparison to 3 T.Magn Reson Med. 2013 Dec;70(6):1619-25. doi: 10.1002/mrm.24616. Epub 2013 Feb 6. Magn Reson Med. 2013. PMID: 23390003 Free PMC article.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources